Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
President
Azura Vascular Care
As president of Azura Vascular Care, Jeff Snodgrass oversees the company’s business activities and provides executive leadership and strategic guidance across the vascular division of Fresenius Medical Care North America. Today, he is leading Azura through the transformation of its vascular access centers to ambulatory surgical centers.
Jeff joined Fresenius Vascular Care in April 2013 as vice president of finance. He led and grew the finance team through a period of significant change and developed a collaborative approach with operations that improved overall performance. In addition, he led the business development group, which closed several acquisitions and developed a pipeline for future acquisitions and de novos.
Jeff’s career spans more than thirty years, with experience in domestic finance, strategy, and general management. His prior roles include chief financial officer at Inventiv Health and various financial leadership positions at Merck & Co. for more than seventeen years. His last role at Merck was as vice president of finance and controller for the company’s global research and development organization.
© 2006-2023 Fresenius Medical Care. All Rights Reserved.